Flutiform Inhaler 50/5 mcg

Pays: Tanzanie

Langue: anglais

Source: Tanzania Medicinces & Medical Devices Authority

Ingrédients actifs:

Formoterol Fumarate ,Fluticasone Propionate

Disponible depuis:

Napp Pharmaceuticals limited, UNITED KINGDOM

DCI (Dénomination commune internationale):

Formoterol Fumarate +Fluticasone Propionate

Dosage:

50/5 mcg

forme pharmaceutique:

Inhaler

Fabriqué par:

Fisons Limited (AVENTIS PHARMA HOLMES CHAPEL), UNITED KINGDOM

Descriptif du produit:

Physical description: White slurry residue after propellant evaporation, free from visible contaminants; Local technical representative: Phillips Pharmaceuticals (Tanzania) Limited

Statut de autorisation:

Registered/Compliant

Date de l'autorisation:

2019-05-15

Afficher l'historique des documents